Cronos Group Announces Streamlined Operating Structure to Improve Cash Flow
Plans to Exit Existing U.S. hemp-derived CBD Operations Intends to Launch Lord Jones® Brand in…
News
Cellectis Publishes an Article in Cancer Immunology Research Demonstrating Preclinical Evidence of UCART20x22 Product Candidate to Target a Broad Spectrum of Patients with B-cell Malignancies
NEW YORK, May 31, 2023 (GLOBE NEWSWIRE) — Cellectis (the “Company”) (Euronext Growth: ALCLS –…
Cellectis Publishes an Article in Cancer Immunology Research Demonstrating Preclinical Evidence of UCART20x22 Product Candidate to Target a Broad Spectrum of Patients with B-cell Malignancies
NEW YORK, May 31, 2023 (GLOBE NEWSWIRE) — Cellectis (the “Company”) (Euronext Growth: ALCLS –…
HOOKIPA Pharma Announces Positive Preliminary Phase 2 Data on HB-200 in Combination with Pembrolizumab in Patients with HPV16+ Head and Neck Cancers
HB-200 in combination with pembrolizumab doubled the objective response rate of 1st-line pembrolizumab for patients…
HOOKIPA Pharma Announces Positive Preliminary Phase 2 Data on HB-200 in Combination with Pembrolizumab in Patients with HPV16+ Head and Neck Cancers
HB-200 in combination with pembrolizumab doubled the objective response rate of 1st-line pembrolizumab for patients…
Structure Therapeutics to Present at Jefferies Healthcare Conference
SAN FRANCISCO and SHANGHAI, May 31, 2023 (GLOBE NEWSWIRE) — Structure Therapeutics Inc. (NASDAQ: GPCR),…
Structure Therapeutics to Present at Jefferies Healthcare Conference
SAN FRANCISCO and SHANGHAI, May 31, 2023 (GLOBE NEWSWIRE) — Structure Therapeutics Inc. (NASDAQ: GPCR),…
Supernus to Participate in the Jefferies Healthcare Conference
ROCKVILLE, Md., May 31, 2023 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical…
Supernus to Participate in the Jefferies Healthcare Conference
ROCKVILLE, Md., May 31, 2023 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical…
Landos Biopharma to Present at the 2023 Jefferies Healthcare Conference
NEW YORK, May 31, 2023 (GLOBE NEWSWIRE) — Landos Biopharma, Inc. (NASDAQ: LABP), a clinical-stage…
Landos Biopharma to Present at the 2023 Jefferies Healthcare Conference
NEW YORK, May 31, 2023 (GLOBE NEWSWIRE) — Landos Biopharma, Inc. (NASDAQ: LABP), a clinical-stage…
Viracta Therapeutics to Present at the Jefferies Healthcare Conference
SAN DIEGO, May 31, 2023 (GLOBE NEWSWIRE) — Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision…
Viracta Therapeutics to Present at the Jefferies Healthcare Conference
SAN DIEGO, May 31, 2023 (GLOBE NEWSWIRE) — Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision…
ORIC Pharmaceuticals to Participate in the Jefferies Healthcare Conference
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, May 31, 2023 (GLOBE NEWSWIRE) — ORIC Pharmaceuticals,…
ORIC Pharmaceuticals to Participate in the Jefferies Healthcare Conference
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, May 31, 2023 (GLOBE NEWSWIRE) — ORIC Pharmaceuticals,…
GENFIT Further Strengthens its ACLF Franchise with a Third Clinical-Stage Asset
Exclusive worldwide rights licensed from Seal Rock Therapeutics for injectable formulation of ASK1 Inhibitor SRT-015…
Western Equity Partners, LLC Announces Strategic Partnership with SB Directional Services
OKLAHOMA CITY–(BUSINESS WIRE)–Western Equity Partners, LLC (“Western” or the “Company”), through its investment partnerships, has…
Cytek Biosciences to Participate in the 44th Annual Goldman Sachs Healthcare Conference
FREMONT, Calif., May 31, 2023 (GLOBE NEWSWIRE) — Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading…
Novra Announces Financial Results for Q1 2023
Winnipeg, Manitoba–(Newsfile Corp. – May 31, 2023) – Novra Technologies Inc. (TSXV: NVI) (OTCQB: NVRVF)…
Hypercharge Announces Inclusion in MSCI Canada Index
Vancouver, British Columbia–(Newsfile Corp. – May 31, 2023) – Hypercharge Networks Corp. (NEO: HC) (OTCQB:…